We are live on ! Find out more
SRAX

SRAX, Inc. Class A Common Stock

Delisted

SRAX was delisted on the 8th of March, 2023.

16 hedge funds and large institutions have $1.75M invested in SRAX, Inc. Class A Common Stock in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

14% more funds holding

Funds holding: 1416 (+2)

10% more capital invested

Capital invested by funds: $1.58M → $1.75M (+$166K)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
2
Reduced
4
Closed
4
Calls
$9K
Puts
Net Calls
+$9K
Net Calls Change
+$9K

SRAX Hedge Fund Activity: Q3 2020 in Review

16 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in SRAX, Inc. Class A Common Stock (SRAX) for Q3 2020, worth a combined $1.75M — up 10% from $1.58M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new SRAX positions and 4 closed out — a net gain of 2 holders — while 2 added to existing stakes and 4 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $84.7K. The largest seller was Invenomic Capital Management, cutting an estimated $268K.

  • 16 institutional investors held SRAX, Inc. Class A Common Stock (SRAX) as of Q3 2020, up from 14 in Q2 2020.
  • Funds reported $1.75M of SRAX, Inc. Class A Common Stock stock for Q3 2020, up 10% quarter-over-quarter.
  • 6 funds opened new SRAX, Inc. Class A Common Stock positions in Q3 2020 and 4 closed out, a net change of +2 holders.
  • The largest SRAX, Inc. Class A Common Stock buyer in Q3 2020 was Citadel Advisors, an estimated $84.7K added.
  • The largest SRAX, Inc. Class A Common Stock seller in Q3 2020 was Invenomic Capital Management, an estimated $268K sold.

Based on aggregated 13F filings for Q3 2020.